
September 12, 2012 Research and Development, Sales and Marketing ABPI, synthetic biology

September 11, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing RNA, drug discovery, therapeutic

September 11, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Brett Haumann, Circassia

September 11, 2012 Research and Development, Sales and Marketing Merck, insomnia, suvorexant

September 11, 2012 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, China, MedImmune, WuXi, emerging markets, rheumatoid arthritis

September 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Thomas, Pfizer, Red Door

September 10, 2012 Research and Development, Sales and Marketing Alimta, Cancer, avastin, lilly, oncology

September 10, 2012 Research and Development, Sales and Marketing Cancer, EGFR, Merck KGaA, oncology

September 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, Paul Stuart Kregor, Paul Stuart-Kregor, marketing, product launch
September 5, 2012 Research and Development
September 5, 2012 Research and Development, Sales and Marketing Andrew Lansley, NHS, NHS reform
September 4, 2012 Research and Development, Sales and Marketing Cancer, Pfizer, VLST, cancer vaccine
September 4, 2012 Research and Development CRO, Charles River, WuXi

September 3, 2012 Research and Development COPD, ERS, Novartis
August 22, 2012 Research and Development, Sales and Marketing Allergan, Molecular Partners, eye diseases